CEO SUMMARY: This will be one of the most challengingĀ years facing the clinical lab industry since the early 1990s. The CMS scheme to collect private payer lab test pricesĀ and use that data to set Medicare clinical laboratory test pricesĀ is proving to be an indiscriminate tool that is poised to undermineĀ the financial integrity of many labs, …
Is There a Future for Hospital Lab Outreach Programs? Read More »
